Literature DB >> 4013610

Catch-up growth following transfer from three times weekly im to daily sc administration of hGH in GH deficient patients, monitored by knemometry.

M Hermanussen, K Geiger-Benoit, W G Sippell.   

Abstract

A novel and non-invasive technique of growth measurement is introduced. By this method the length of the human lower leg is measured with an accuracy of 0.1 mm. Thus, growth velocities can be estimated within a few weeks. In the present study the immediate changes of growth velocity are demonstrated, following the transfer of growth hormone administration from three times weekly im to daily sc in 9 growth hormone deficient children, age 7.4 to 20.5 years. The first observation period (3 times weekly im administration) ranged from 32 to 72 days, the second observation period (daily sc administration) ranged from 160 to 267 days). During the study, the total weekly dosage of growth hormone remained unchanged (12 IU/m2/week). In all 9 patients growth velocity increased significantly after the transfer of application. Mean growth velocity of the lower leg rose from 0.04 mm/day up to 0.065 mm/day. Mean growth velocity of total body height rose form 4.8 cm/year up to 6.9 cm/year. In addition, differential lower leg growth rates of 3 to 4 week periods were established in all 9 patients, revealing a significant catch-up growth spurt immediately following the transfer of application. During this spurt mean lower leg growth velocity rose form 0.04 mm/day up to 0.091 mm/day. This marked increase of lower leg growth rates lasted for only a few weeks and was followed by a period of decreased growth velocity. On the long run, growth velocity shifted upward in a wave-like pattern, stabilizing on a significantly higher level than before the transfer of application.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4013610     DOI: 10.1530/acta.0.1090163

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  10 in total

1.  Methionyl human growth hormone in Turner's syndrome.

Authors:  C Rongen-Westerlaken; J M Wit; S L Drop; B J Otten; W Oostdijk; H A Waal; M H Gons; A Bot; J L Van den Brande
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

2.  Short term linear growth in asthmatic children during treatment with prednisolone.

Authors:  O D Wolthers; S Pedersen
Journal:  BMJ       Date:  1990-07-21

3.  Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group.

Authors:  B Boersma; B Rikken; J M Wit
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

4.  The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.

Authors:  P A Baldwin; C K Klingbeil; C J Grimm; J P Longenecker
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

5.  "Negative growth" in anorexia nervosa assessed by knemometry.

Authors:  M Hermanussen; K Geiger-Benoit; W G Sippell
Journal:  Eur J Pediatr       Date:  1987-11       Impact factor: 3.183

Review 6.  Knemometry, a new tool for the investigation of growth. A review.

Authors:  M Hermanussen
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

7.  Growth hormone therapy with a new delivery system.

Authors:  J T Jørgensen; S Susgaard
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

8.  Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®.

Authors:  Kevin C J Yuen; Rakesh Amin
Journal:  Patient Prefer Adherence       Date:  2011-03-10       Impact factor: 2.711

Review 9.  Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes.

Authors:  Yunpeng Cai; Mingxin Xu; Minglu Yuan; Zhenguo Liu; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2014-07-25

10.  Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers.

Authors:  Andrew L Lewis; Faron Jordan; Tina Patel; Kirk Jeffery; Gareth King; Martin Savage; Stephen Shalet; Lisbeth Illum
Journal:  J Clin Endocrinol Metab       Date:  2015-10-01       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.